These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 37277810)
1. Metabolomics analysis of the potential mechanism of Yi-Guan-Jian decoction to reverse bone loss in glucocorticoid-induced osteoporosis. Yin M; Zhou D; Jia F; Su X; Li X; Sun R; Li J J Orthop Surg Res; 2023 Jun; 18(1):409. PubMed ID: 37277810 [TBL] [Abstract][Full Text] [Related]
2. Untargeted metabolomics revealed the mechanism of aucubin on glucocorticoid-induced osteoporosis in mice through modulating arachidonic acid metabolism. Wang H; Zhao Y; Liu H; Zhang X; Lv S; Zhou T; Cui H; Zhao J; Li X J Pharm Biomed Anal; 2024 Sep; 248():116273. PubMed ID: 38878451 [TBL] [Abstract][Full Text] [Related]
3. Metabolomics profiling provides valuable insights into the underlying mechanisms of Morinda officinalis on protecting glucocorticoid-induced osteoporosis. Xia T; Dong X; Lin L; Jiang Y; Ma X; Xin H; Zhang Q; Qin L J Pharm Biomed Anal; 2019 Mar; 166():336-346. PubMed ID: 30690247 [TBL] [Abstract][Full Text] [Related]
4. Metabonomic analysis of serum reveals antifatigue effects of Yi Guan Jian on fatigue mice using gas chromatography coupled to mass spectrometry. Shui S; Cai X; Huang R; Xiao B; Yang J Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28868653 [TBL] [Abstract][Full Text] [Related]
5. Metabonomic analysis of biochemical changes in the plasma and urine of carrageenan-induced rats after treatment with Yi-Guan-Jian decoction. Shui S; Shen S; Huang R; Xiao B; Yang J J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():80-90. PubMed ID: 27525358 [TBL] [Abstract][Full Text] [Related]
6. Effects of the combined Herba Epimedii and Fructus Ligustri Lucidi on bone turnover and TGF-β1/Smads pathway in GIOP rats. Yang Y; Nian H; Tang X; Wang X; Liu R J Ethnopharmacol; 2017 Apr; 201():91-99. PubMed ID: 28254481 [TBL] [Abstract][Full Text] [Related]
7. Isopsoralen Improves Glucocorticoid-induced Osteoporosis by Regulating Purine Metabolism and Promoting cGMP/PKG Pathway-mediated Osteoblast Differentiation. Liu D; Ma L; Zheng J; Zhang Z; Zhang N; Han Z; Wang X; Zhao J; Lv S; Cui H Curr Drug Metab; 2024; 25(4):288-297. PubMed ID: 39005121 [TBL] [Abstract][Full Text] [Related]
8. Icariin ameliorates dexamethasone‑induced bone deterioration in an experimental mouse model via activation of microRNA‑186 inhibition of cathepsin K. Ma Y; Yang H; Huang J Mol Med Rep; 2018 Jan; 17(1):1633-1641. PubMed ID: 29257214 [TBL] [Abstract][Full Text] [Related]
10. Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9. Li G; Bu J; Zhu Y; Xiao X; Liang Z; Zhang R Int J Clin Exp Pathol; 2015; 8(12):15684-95. PubMed ID: 26884838 [TBL] [Abstract][Full Text] [Related]
11. The role of Serpina3n in the reversal effect of ATRA on dexamethasone-inhibited osteogenic differentiation in mesenchymal stem cells. Jiang HT; Deng R; Deng Y; Nie M; Deng YX; Luo HH; Yang YY; Ni N; Ran CC; Deng ZL Stem Cell Res Ther; 2021 May; 12(1):291. PubMed ID: 34001245 [TBL] [Abstract][Full Text] [Related]
12. The investigation of anti-inflammatory activity of Yi Guanjian decoction by serum metabonomics approach. Shui S; Cai X; Huang R; Xiao B; Yang J J Pharm Biomed Anal; 2017 Jan; 133():41-48. PubMed ID: 27856104 [TBL] [Abstract][Full Text] [Related]
13. ED-71 Prevents Glucocorticoid-Induced Osteoporosis by Regulating Osteoblast Differentiation via Notch and Wnt/β-Catenin Pathways. Rong X; Kou Y; Zhang Y; Yang P; Tang R; Liu H; Li M Drug Des Devel Ther; 2022; 16():3929-3946. PubMed ID: 36411860 [TBL] [Abstract][Full Text] [Related]
14. Total Flavonoids of Drynariae Rhizoma Improve Glucocorticoid-Induced Osteoporosis of Rats: UHPLC-MS-Based Qualitative Analysis, Network Pharmacology Strategy and Pharmacodynamic Validation. Zhang F; Li Q; Wu J; Ruan H; Sun C; Zhu J; Song Q; Wei X; Shi Y; Zhu L Front Endocrinol (Lausanne); 2022; 13():920931. PubMed ID: 35846330 [TBL] [Abstract][Full Text] [Related]
15. Myricetin ameliorates glucocorticoid-induced osteoporosis through the ERK signaling pathway. Fan S; Gao X; Chen P; Li X Life Sci; 2018 Aug; 207():205-211. PubMed ID: 29883721 [TBL] [Abstract][Full Text] [Related]
16. Effects of glucocorticoid-induced osteoporosis on bone tissue of rats with experimental periodontitis. Sousa LH; Moura EV; Queiroz AL; Val D; Chaves H; Lisboa M; Furlaneto F; Brito GA; Goes P Arch Oral Biol; 2017 May; 77():55-61. PubMed ID: 28178585 [TBL] [Abstract][Full Text] [Related]
17. [Mechanisms and therapeutics of glucocorticoid-induced osteoporosis]. Kaneko K; Kawai S Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(3):138-48. PubMed ID: 21720102 [TBL] [Abstract][Full Text] [Related]
18. Yang Y; Yu T; Tang H; Ren Z; Li Q; Jia J; Chen H; Fu J; Ding S; Hao Q; Xu D; Song L; Sun B; Sun F; Pei J Front Pharmacol; 2020; 11():731. PubMed ID: 32508652 [TBL] [Abstract][Full Text] [Related]
19. Liraglutide increases bone formation and inhibits bone resorption in rats with glucocorticoid-induced osteoporosis. Yang L; Yang J; Pan T; Zhong X J Endocrinol Invest; 2019 Sep; 42(9):1125-1131. PubMed ID: 30955181 [TBL] [Abstract][Full Text] [Related]